Effect of Sirolimus on Molecular Alterations in Cerebral Aneurysms
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
This PHASE2 trial investigates Cerebral Aneurysm and is currently actively recruiting participants. National Institute of Neurological Disorders and Stroke (NINDS) leads this study, which shows 22 recorded versions since 2021 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
22 versions recorded-
Apr 2025 — Present [monthly]
Recruiting PHASE2
-
Sep 2024 — Apr 2025 [monthly]
Recruiting PHASE2
-
Aug 2024 — Sep 2024 [monthly]
Recruiting PHASE2
-
Jul 2024 — Aug 2024 [monthly]
Recruiting PHASE2
-
Sep 2023 — Jul 2024 [monthly]
Recruiting PHASE2
▶ Show 17 earlier versions
-
Sep 2022 — Sep 2023 [monthly]
Recruiting PHASE2
-
Dec 2021 — Sep 2022 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Sep 2021 — Dec 2021 [monthly]
Not Yet Recruiting PHASE2
-
Jun 2021 — Sep 2021 [monthly]
Not Yet Recruiting PHASE2
-
Apr 2021 — Jun 2021 [monthly]
Not Yet Recruiting PHASE2
-
Feb 2021 — Apr 2021 [monthly]
Not Yet Recruiting PHASE2
-
Jan 2021 — Feb 2021 [monthly]
Not Yet Recruiting PHASE2
-
Dec 2020 — Jan 2021 [monthly]
Not Yet Recruiting PHASE2
-
Oct 2020 — Dec 2020 [monthly]
Not Yet Recruiting PHASE2
-
Sep 2020 — Oct 2020 [monthly]
Not Yet Recruiting PHASE2
-
Aug 2020 — Sep 2020 [monthly]
Not Yet Recruiting PHASE2
-
Jun 2020 — Aug 2020 [monthly]
Not Yet Recruiting PHASE2
-
May 2020 — Jun 2020 [monthly]
Not Yet Recruiting PHASE2
-
Apr 2020 — May 2020 [monthly]
Not Yet Recruiting PHASE2
-
Mar 2020 — Apr 2020 [monthly]
Not Yet Recruiting PHASE2
-
Feb 2020 — Mar 2020 [monthly]
Not Yet Recruiting PHASE2
-
Nov 2019 — Feb 2020 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Neurological Disorders and Stroke (NINDS)
- University of Miami
For direct contact, visit the study record on ClinicalTrials.gov .